Lv3
370 积分 2024-10-25 加入
The efficacy and safety of total glucosides of peony in the treatment of primary Sjögren's syndrome: a multi-center, randomized, double-blinded, placebo-controlled clinical trial
1个月前
已完结
Adalimumab-Based Treatment Versus Disease-Modifying Antirheumatic Drugs for Venous Thrombosis in Behçet's Syndrome: A Retrospective Study of Seventy Patients With Vascular Involvement
1个月前
已完结
Infliximab for vascular involvement in Behçet's syndrome
1个月前
已完结
Infliximab versus Cyclophosphamide for Severe Behçet's Syndrome
1个月前
已完结
Infliximab versus Cyclophosphamide for Severe Behçet’s Syndrome
1个月前
已完结
Combinations of immunomodulatory agents for prevention of uveitis relapse in patients with severe Behçet's disease already on corticosteroid therapy: a randomised, open-label, head-to-head trial
2个月前
已完结
A single infliximab infusion vs corticosteroids for acute panuveitis attacks in Behçet’s disease: a comparative 4-week study
2个月前
已完结
High-dose intravenous steroid pulse therapy in ocular involvement of Behcet's disease: a pilot double-blind controlled study
2个月前
已完结
Efficacy and safety of infliximab or adalimumab in severe mucocutaneous Behcet ¸ ’s syndrome refractory to traditional immunosuppressants: a 6-month, multicentre, randomised controlled, prospective, parallel group, single-blind trial
2个月前
已关闭
Update on the pathophysiology and treatment of primary Sjögren syndrome
8个月前
已完结
皖公网安备34019202002308
